Yanyun Gao

Yangzhou University

H指数:21

被引数:1,274

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Global emergence and transmission dynamics of carbapenemase-producing Citrobacter freundii sequence type 22 high-risk international clone: a retrospective, genomic, epidemiological study

全球产碳青霉烯酶的弗劳地柠檬酸杆菌序列型22高危国际克隆的出现与传播动态：一项回顾性、基因组学及流行病学研究

lancet microbe

IF0

2025-07-160

OAAI

POLR1A inhibits ferroptosis by regulating TFAM-mediated mitophagy and iron homeostasis

POLR1A通过调控TFAM介导的线粒体自噬和铁稳态来抑制铁死亡。

Redox Biology

IF11.9

2025-07-080

PRE

Inhibition of LDHB suppresses the metastatic potential of lung cancer by reducing mitochondrial GSH catabolism

CANCER LETTERS

IF10.1

2025-02-010

OAAI

Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer

CELL DEATH AND DIFFERENTIATION

IF15.4

2024-12-070

OAAI

Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment

化疗增加CDA表达并使恶性胸膜间皮瘤细胞对卡培他滨治疗敏感

SCIENTIFIC REPORTS

IF3.9

2024-08-060

OAAI

BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma

BAP1缺乏会刺激肿瘤免疫微环境，是恶性胸膜间皮瘤免疫治疗反应的候选生物标志物

JTO CLINICAL AND RESEARCH REPORTS

IF3.5

2024-05-012

Adaptive evolution of plasmid and chromosome contributes to the fitness of a blaNDM-bearing cointegrate plasmid in Escherichia coli

ISME JOURNAL

IF10

2024-03-042

OAAI

Dynamic evolution and transmission of a blaNDM-1-bearing fusion plasmid in a clinical Escherichia coli

blaNDM-1-bearing融合质粒在临床大肠杆菌中的动态进化和传播

MICROBIOLOGICAL RESEARCH

IF6.9

2023-10-017

PRE

MEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma

CELL DEATH DISCOVERY

IF7

2023-02-107

OAAI

Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2022-07-2524

OAAI

Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis

FRONTIERS IN ONCOLOGY

IF3.3

2022-04-298

OAAI

Recent advances of chitosan-based nanoparticles for biomedical and biotechnological applications

基于壳聚糖的纳米粒子在生物医学和生物技术中的应用研究进展

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2022-04-0192

PRE

Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer

KRAS突变型肺癌中靶向NOP56和mTOR的代谢合成致死率

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2022-01-179

OAAI

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer

EMBO MOLECULAR MEDICINE

IF8.3

2021-08-0813

OAAI

Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5′-deoxy-5-fluorocytidine (5′-DFCR)

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2021-04-1911

OAAI

Morphological factors associated with giant vacuoles with I-pores in Schlemm?s canal endothelial cells of human eyes: A serial block-face scanning electron microscopy study

EXPERIMENTAL EYE RESEARCH

IF2.7

2021-04-0120

OAAI

CRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for FGFR1-Amplified Lung Cancer

CANCER RESEARCH

IF16.6

2021-03-0817

CRISPR Screening Identifies WEE1 as a Combination Target for Standard Chemotherapy in Malignant Pleural Mesothelioma

MOLECULAR CANCER THERAPEUTICS

IF5.5

2020-02-0626

OAAI

Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment

CANCER CELL INTERNATIONAL

IF6

2019-11-2925

OAAI

HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer

ONCOGENESIS

IF6.4

2019-08-2043

OAAI

Yanyun Gao

个人简介

教育背景

工作经历

荣誉奖项

研究方向